June 7, 2022
Drug Checking (Q2 2022): Philadelphia, Pennsylvania, USA
Summary and Key Findings:
  • 90 samples were reported between March and early-May 2022
  • Most “heroin”/dope samples contained fentanyl and xylazine
  • Fentanyl-xylazine (tranq-dope) proportions varied greatly
  • para-Fluorofentanyl continues its presence in dope samples
  • Two cocaine (coke) samples contained trace levels of fentanyl, while methamphetamine samples were not adulterated
  • Two counterfeit oxycodone tablets contained fentanyl
  • Tenocyclidine was detected in samples purported to be “PCP”
Download the Report